Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString to Present at the Stifel 2019 Healthcare Conference
SEATTLE --(BUSINESS WIRE)--Nov. 13, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Stifel 2019 Healthcare
View HTML
Toggle Summary NanoString Highlights the Results of Research Presented at the 2019 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
Presentations Include Data from More than Thirty NanoString-Related Abstracts Including Five Using the GeoMx Digital Spatial Profiler SEATTLE --(BUSINESS WIRE)--Nov. 7, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and
View HTML
Toggle Summary NanoString Technologies Releases Operating Results for Third Quarter of 2019
SEATTLE --(BUSINESS WIRE)--Nov. 4, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the third quarter of 2019. This press release features multimedia.
View HTML
Toggle Summary NanoString Announces Availability of the GeoMx Cancer Transcriptome Atlas Through the Technology Access Program for Digital Spatial Profiling
Spatial Analysis of More Than 1,600 Key Cancer Genes from Fresh Frozen and Formalin-Fixed Paraffin-Embedded Tissue SEATTLE --(BUSINESS WIRE)--Nov. 4, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic
View HTML
Toggle Summary NanoString Technologies Supports the Human Cell Atlas (HCA) to Enable High-plex Spatial Analysis Across Discovery Programs
A Global Collaboration with 1000+ HCA Research Institutes SEATTLE --(BUSINESS WIRE)--Nov. 4, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it will support the Human Cell Atlas
View HTML
Toggle Summary NanoString Appoints Don Kania, Ph.D. to its Board of Directors
SEATTLE --(BUSINESS WIRE)--Oct. 31, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Don Kania , Ph.D. to its board of directors, effective October 30, 2019 .
View HTML
Toggle Summary NanoString to Release Third Quarter 2019 Financial Results and Host Conference Call on Monday, November 4, 2019
  SEATTLE --(BUSINESS WIRE)--Oct. 7, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release third quarter 2019 financial results after the close of trading on
View HTML
Toggle Summary NanoString Reports Inducement Grant Under NASDAQ Listing Rules
  SEATTLE --(BUSINESS WIRE)--Oct. 4, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported, as required by NASDAQ Stock Market Rules, an equity inducement award to Mark Winham , the Company’s
View HTML
Toggle Summary NanoString Appoints Mark Winham Senior Vice President of Operations
  SEATTLE --(BUSINESS WIRE)--Oct. 2, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Mark Winham as senior vice president of Operations effective October 2, 2019 .
View HTML
Toggle Summary NanoString Introduces New Gene Expression Research Panel for Human Organ Transplantation
  Created in Collaboration with Banff Consortium to Study Mechanisms of Organ Rejection     SEATTLE --(BUSINESS WIRE)--Sep. 23, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the
View HTML